Provider of healthcare solutions Ambu A/S (CPH:AMBUB) announced on Monday that Allan Søgaard Larsen has decided to withdraw from the company's board of directors, effective immediately.
The company said Larsen, who has since 2011 has been a member of the board of directors in Ambu, is leaving for personal reasons.
Ambu develops, produces and markets life-saving equipment. The company provides professional diagnostic, life supporting and training equipment. Its products are used for respiratory support and cardiopulmonary resuscitation, immobilisation and protection against infections.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
D3 Bio announces Series A+ Round completion to advance innovative oncology pipeline
Dizal's sunvozertinib receives US FDA Breakthrough Therapy Designation
Merck launches Phase 3 trial of MK-1084 and KEYTRUDA combination in metastatic NSCLC
Trevi Therapeutics names new vice president of Clinical Development
Personalis validates NeXT Personal test for ultra-sensitive MRD detection
Merck reports lung cancer trial failed to meet endpoints
BerGenBio ASA starts Phase 2a portion of BGBC016 clinical study of bemcentinib